文献速递系统性红斑狼疮其他结缔组织病

系统性红斑狼疮患者支气管扩张症的发病率与疾病负担:韩国全国性人群研究

Incidence and disease burden of bronchiectasis in systemic lupus erythematosus: a nationwide population-based study in Korea.
PubMed 文献 · RMD Open · 2026-06-22

基于韩国国民健康保险服务数据的人群匹配队列研究显示,成人SLE患者支气管扩张症发病率高于对照(374.8 vs 236.2/10万人年),风险增加1.46倍(95%CI 1.22-1.76),且合并支气管扩张者死亡率、急诊就诊和住院率更高。

要点

  • SLE患者支气管扩张症发病风险较匹配对照增加46%。
  • SLE患者中年龄>40岁和哮喘与支气管扩张风险升高相关。
  • SLE合并支气管扩张者死亡及医疗资源使用显著增加。

核心结论

  • SLE患者支气管扩张症风险高于匹配对照,且合并支气管扩张与更差疾病病程、更高死亡率和医疗资源使用增加相关。

研究设计与样本

  • 基于韩国国民健康保险服务数据集的全国性人群匹配队列研究,纳入2002-2012年确诊的≥20岁成人SLE患者及按1:4年龄、性别和医保服务匹配的对照。
  • 从入组1年后开始随访,直至支气管扩张诊断、死亡或2019年12月31日。

主要发现

  • 中位随访12.8年(IQR 10.0-16.0年)期间,SLE队列支气管扩张症发病率高于匹配对照(374.8 vs 236.2/10万人年,p<0.001)。
  • SLE队列发生支气管扩张的风险为匹配队列的1.46倍(95%CI 1.22-1.76)。
  • SLE队列内,年龄>40岁(≥70岁者aHR最高为25.08,95%CI 7.62-82.53)和哮喘(aHR 1.73,95%CI 1.11-2.70)与支气管扩张风险升高相关。
  • 肥胖与支气管扩张风险呈负相关(aHR 0.56,95%CI 0.38-0.82)。
  • SLE合并支气管扩张者的死亡率、急诊就诊率和住院率显著高于未发生支气管扩张者。

临床怎么用

  • 对SLE患者,尤其是年龄>40岁或合并哮喘者,应警惕支气管扩张症的发生。
  • SLE患者若诊断支气管扩张,需关注其更高的死亡风险和医疗资源使用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Pulmonary abnormalities, such as interstitial lung disease, have been relatively well studied in patients with systemic lupus erythematosus (SLE). However, it remains unclear whether the risk of bronchiectasis and its associated disease burden are increased in SLE. METHODS: Using the Korean National Health Insurance Service dataset, we conducted a population-based matched cohort study involving adults aged ≥20 years diagnosed with SLE (SLE cohort) between 2002 and 2012 and a 1:4 age, sex and health insurance service-matched cohort (matched controls). Beginning 1 year after enrolment, participants were followed until the date of a bronchiectasis diagnosis, death or 31 December 2019, whichever came first. RESULTS: During a median follow-up of 12.8 years (IQR 10.0-16.0 years), the incidence rate of bronchiectasis was higher in the SLE cohort than in the matched controls (374.8 vs 236.2/100 000 person-years, p<0.001). The SLE cohort showed a 1.46-fold (95% CI 1.22 to 1.76) increased risk of developing bronchiectasis compared with the matched cohort. Within the SLE cohort, age older than 40 years (highest adjusted HR (aHR) in those ≥70 years 25.08, 95% CI 7.62 to 82.53) and asthma (aHR 1.73, 95% CI 1.11 to 2.70) were associated with an increased risk of bronchiectasis. In contrast, obesity was inversely associated with the risk of bronchiectasis (aHR 0.56, 95% CI 0.38 to 0.82). Individuals with SLE who developed bronchiectasis had significantly higher rates of mortality, emergency department visits and hospitalisations than those who did not develop bronchiectasis. CONCLUSIONS: The risk of bronchiectasis was higher in individuals with SLE than in controls, and its development was associated with a worse disease course, higher mortality during follow-up and increased healthcare utilisation.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Min G, Kye DE, Lee H, et al. Incidence and disease burden of bronchiectasis in systemic lupus erythematosus: a nationwide population-based study in Korea. RMD Open. 2026. PMID: 42331395. doi:10.1136/rmdopen-2025-006671

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。